NO991292L - Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser - Google Patents

Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser

Info

Publication number: NO991292L
Authority: NO; Norway
Prior art keywords: neurological disorders; spasticity; benzopyranols; neuralgia; disorders
Prior art date: 1996-09-18

Application number

NO991292A

Other languages

English (en)

Norwegian (no)

Other versions

NO991292D0 (no

Inventor

Andrew A Parsons

Mervyn Thompson

Neil Upton

John Morris Evans

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-18

Filing date

1999-03-17

Publication date

1999-03-17

1999-03-17 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1999-03-17 Publication of NO991292D0 publication Critical patent/NO991292D0/no

1999-03-17 Publication of NO991292L publication Critical patent/NO991292L/no

Links

208000012902 Nervous system disease Diseases 0.000 title abstract 2
208000025966 Neurological disease Diseases 0.000 title abstract 2
SERVTOXIOYSDQO-UHFFFAOYSA-N 2h-chromen-2-ol Chemical class C1=CC=C2C=CC(O)OC2=C1 SERVTOXIOYSDQO-UHFFFAOYSA-N 0.000 title 1
208000008238 Muscle Spasticity Diseases 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
208000004296 neuralgia Diseases 0.000 abstract 2
208000018198 spasticity Diseases 0.000 abstract 2
208000030507 AIDS Diseases 0.000 abstract 1
206010003591 Ataxia Diseases 0.000 abstract 1
206010058019 Cancer Pain Diseases 0.000 abstract 1
208000017164 Chronobiology disease Diseases 0.000 abstract 1
208000023105 Huntington disease Diseases 0.000 abstract 1
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 1
208000009205 Tinnitus Diseases 0.000 abstract 1
208000030886 Traumatic Brain injury Diseases 0.000 abstract 1
150000001562 benzopyrans Chemical class 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
206010022437 insomnia Diseases 0.000 abstract 1
201000003631 narcolepsy Diseases 0.000 abstract 1
230000008035 nerve activity Effects 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
210000002569 neuron Anatomy 0.000 abstract 1
208000021722 neuropathic pain Diseases 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
201000000980 schizophrenia Diseases 0.000 abstract 1
208000019116 sleep disease Diseases 0.000 abstract 1
230000002123 temporal effect Effects 0.000 abstract 1
231100000886 tinnitus Toxicity 0.000 abstract 1
208000004371 toothache Diseases 0.000 abstract 1
230000009529 traumatic brain injury Effects 0.000 abstract 1
206010044652 trigeminal neuralgia Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)

NO991292A 1996-09-18 1999-03-17 Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser NO991292L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9619492.3A GB9619492D0 (en)	1996-09-18	1996-09-18	Novel treatment
PCT/EP1997/005168 WO1998011890A1 (en)	1996-09-18	1997-09-15	Use of benzopyranols to treat neurological disorders

Publications (2)

Publication Number	Publication Date
NO991292D0 NO991292D0 (no)	1999-03-17
NO991292L true NO991292L (no)	1999-03-17

Family

ID=10800127

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO991292A NO991292L (no)	1996-09-18	1999-03-17	Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser

Country Status (30)

Country	Link
EP (1)	EP0939630B1 (de)
JP (1)	JP2001500520A (de)
KR (1)	KR20000036184A (de)
CN (1)	CN1230885A (de)
AP (1)	AP9901473A0 (de)
AR (1)	AR008838A1 (de)
AT (1)	ATE270102T1 (de)
AU (1)	AU730465B2 (de)
BG (1)	BG103252A (de)
BR (1)	BR9712030A (de)
CA (1)	CA2266681A1 (de)
DE (1)	DE69729735T2 (de)
DZ (1)	DZ2311A1 (de)
EA (1)	EA199900306A1 (de)
ES (1)	ES2223075T3 (de)
GB (1)	GB9619492D0 (de)
HU (1)	HUP9904638A3 (de)
ID (2)	ID23175A (de)
IL (1)	IL128786A0 (de)
MA (1)	MA24321A1 (de)
NO (1)	NO991292L (de)
NZ (1)	NZ334271A (de)
OA (1)	OA10998A (de)
PE (1)	PE109898A1 (de)
PL (1)	PL332313A1 (de)
SK (1)	SK35199A3 (de)
TR (1)	TR199900527T2 (de)
UY (1)	UY24717A1 (de)
WO (1)	WO1998011890A1 (de)
ZA (1)	ZA978359B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7119214B2 (en) *	2004-04-13	2006-10-10	Cephalon France	Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US20110319482A1 (en) *	2008-06-05	2011-12-29	Peter Blower	Novel treatments
US20130281524A1 (en) *	2008-06-05	2013-10-24	Peter Blower	Novel treatments
PT2464645T (pt)	2009-07-27	2017-10-11	Gilead Sciences Inc	Compostos heterocíclicos fusionados como moduladores do canal de iões
AU2010325755A1 (en) *	2009-12-03	2012-06-21	Proximagen Ltd	Treatment of infectious diseases
WO2011067608A1 (en) *	2009-12-03	2011-06-09	Minster Research Ltd	Treatment of allodynia and hyperalgesia
WO2012003392A1 (en)	2010-07-02	2012-01-05	Gilead Sciences, Inc.	Fused heterocyclic compounds as ion channel modulators
AU2012253653A1 (en)	2011-05-10	2013-05-02	Gilead Sciences, Inc.	Fused heterocyclic compounds as sodium channel modulators
NO3175985T3 (de)	2011-07-01	2018-04-28
TWI622583B (zh)	2011-07-01	2018-05-01	基利科學股份有限公司	作為離子通道調節劑之稠合雜環化合物
CN106397317B (zh) *	2016-09-26	2019-03-22	天津师范大学	1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9112721D0 (en) *	1991-06-13	1991-07-31	Smithkline Beecham Plc	Novel treatment
US5510375A (en) *	1993-11-19	1996-04-23	Warner-Lambert Company	Coumarin derivatives as protease inhibitors and antiviral agents
GB9411635D0 (en) *	1994-06-10	1994-08-03	Smithkline Beecham Plc	Novel treatment
ATE250052T1 (de) *	1994-06-10	2003-10-15	Smithkline Beecham Plc	Benzopyrane und deren verwendung als heilmittel

1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
1997
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 EP EP97909300A patent/EP0939630B1/de not_active Expired - Lifetime
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Ceased
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Withdrawn
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292L/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown

Also Published As

Publication number	Publication date
SK35199A3 (en)	2000-07-11
TR199900527T2 (xx)	1999-06-21
WO1998011890A1 (en)	1998-03-26
ZA978359B (en)	1999-03-17
CN1230885A (zh)	1999-10-06
NZ334271A (en)	2001-03-30
EP0939630A1 (de)	1999-09-08
CA2266681A1 (en)	1998-03-26
HUP9904638A3 (en)	2001-08-28
ES2223075T3 (es)	2005-02-16
AU4704797A (en)	1998-04-14
UY24717A1 (es)	2001-08-27
IL128786A0 (en)	2000-01-31
EP0939630B1 (de)	2004-06-30
AR008838A1 (es)	2000-02-23
NO991292D0 (no)	1999-03-17
DZ2311A1 (fr)	2002-12-28
HUP9904638A2 (hu)	2001-05-28
KR20000036184A (ko)	2000-06-26
PL332313A1 (en)	1999-08-30
EA199900306A1 (ru)	1999-08-26
MA24321A1 (fr)	1998-04-01
DE69729735T2 (de)	2005-07-14
AP9901473A0 (en)	1999-03-31
JP2001500520A (ja)	2001-01-16
ATE270102T1 (de)	2004-07-15
BG103252A (en)	1999-09-30
AU730465B2 (en)	2001-03-08
PE109898A1 (es)	1999-03-21
OA10998A (en)	2003-03-04
ID19542A (id)	1998-07-23
DE69729735D1 (de)	2004-08-05
BR9712030A (pt)	1999-08-24
GB9619492D0 (en)	1996-10-30
ID23175A (id)	2000-03-23

Legal Events

Date	Code	Title	Description
2003-06-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ATE258796T1 (de)	2004-02-15	Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE381935T1 (de)	2008-01-15	Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
DE69533040D1 (de)	2004-06-17	Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
PT822829E (pt)	2002-06-28	Utilizacao do factor neurotrofico da glia (gdnf) para o tratamento de desordens da audicao
DE60042137D1 (de)	2009-06-10	Rekombinante alpha-l-iduronidase und behandlung von durch diese hervorgerufene mangelerkrankungen
WO2003092617A3 (en)	2004-05-13	Combinations for the treatment of inflammatory skin disorders
SV1995000007A (es)	1996-02-28	Derivados del acido micofenolico 5-substituidos.
ES2194025T3 (es)	2003-11-16	Toxinas botulinicas multiples para tratar trastornos y enfermedades neuromusculares.
ATE213411T1 (de)	2002-03-15	Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
DE59907752D1 (de)	2003-12-18	Verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien
FR2721516B1 (fr)	1996-09-13	Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation.
DE69923998D1 (de)	2005-04-07	Verwendung eines neurologischen wirkstoffes zur herstellung eines medikamentes zur behandlung von erkrankungen des zentralen nervensystems
MY134778A (en)	2007-12-31	Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
ZA865735B (en)	1987-11-25	Pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
Latha et al.	1992	Efficacy of yoga therapy in the management of headaches.
AP9901473A0 (en)	1999-03-31	Use of benzopyranols to treat neurological disorders.
WO2003057162A3 (en)	2003-12-24	Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
MY120530A (en)	2005-11-30	Combination preparation for use in dementia
MXPA03001160A (es)	2004-08-02	Metodo para tratar desordenes neurodegenerativos de la retina y cabeza de nervio optico.
PH22534A (en)	1988-10-17	Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide
WO2002030411A8 (en)	2002-07-11	Treatment of apoptotic cell death
ATE260108T1 (de)	2004-03-15	Verwendung von citicoline zur behandlung von multipler sklerose
ATE369143T1 (de)	2007-08-15	Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE320263T1 (de)	2006-04-15	Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
WO2000001440A3 (en)	2000-04-20	Methods for treating neurological injuries and disorders